Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Aug 26, 2013; 5(8): 313-316
Published online Aug 26, 2013. doi: 10.4330/wjc.v5.i8.313
Published online Aug 26, 2013. doi: 10.4330/wjc.v5.i8.313
Longitudinal stent compression of everolimus-eluting stent: A report of 2 cases
Rajesh Vijayvergiya, Alok Kumar, Smit Shrivastava, Naveen K Kamana, Department of Cardiology, Advanced Cardiac Centre, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
Author contributions: All authors were actively involved in management of the index cases.
Correspondence to: Dr. Rajesh Vijayvergiya, MD, DM, FSCAI, FISES, FACC, Associate Professor, Department of Cardiology, Advanced Cardiac Centre, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India. rajeshvijay999@hotmail.com
Telephone: +91-172-2756512 Fax: +91-172-2744401
Received: March 19, 2013
Revised: May 1, 2013
Accepted: July 17, 2013
Published online: August 26, 2013
Processing time: 170 Days and 0.7 Hours
Revised: May 1, 2013
Accepted: July 17, 2013
Published online: August 26, 2013
Processing time: 170 Days and 0.7 Hours
Core Tip
Core tip: The newer second generation drug eluting stent (DES) have shown a greater safety and efficacy compared to first generation DES, because of thinner struts, nondurable polymers and coating with better anti-proliferative drugs. Though their performance is excellent for various type of coronary lesions, one downside is that they are susceptible for compression/ deformation because of poor longitudinal axial strength. We came across longitudinal stent compression (LSC) of everolimus-eluting stent in two cases, which was successfully managed by balloon dilatation. Various reasons for LSC and its management are discussed in the article.